Adam Yala is a physician-trained machine learning researcher and entrepreneur who builds AI systems to personalize cancer screening and treatment and translates them into clinical practice. As founder and CEO of Voio and an assistant professor at UC Berkeley and UCSF, he bridges academic rigor with product-driven deployment, with tools already implemented across multiple hospital systems and informing prospective clinical trials. His work spans modeling multimodal patient records, deriving decision-making policies from AI predictors, and providing decision guarantees that clinicians can act on. Trained at MIT (BS, MS, PhD) and experienced at MIT CSAIL and industry labs, he combines deep research in probabilistic modeling and clinical translation with hands-on engineering leadership. Based in Berkeley, he brings 11 years of experience turning complex biomedical data into actionable interventions and operational clinical tools. A less obvious strength is his emphasis on decision-focused guarantees—ensuring AI recommendations align with patient risks and preferences rather than just optimizing predictive metrics.
11 years of coding experience
8 years of employment as a software developer
Doctor of Philosophy (PhD) Computer Science, Doctor of Philosophy (PhD) Computer Science at Massachusetts Institute of Technology
OncoText is an information extraction service for breast pathology reports. It supports over 20 categories including DCIS, includes pretrained models, and supports flexible addition of new categories, new training data, and parsing new reports.
Contributions:38 commits, 12 PRs, 38 pushes in 9 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.